At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description At Syngenta Crop Protection, were pioneering solutions that safeguard global food security while championing sustainable agriculture. As a world market leader headquartered in Switzerland, we empower farmers with innovative crop protection technologies that defend against natures
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF169,400.00 - CHF314,600.00 Job Description Summary#LI-Hybrid Internal Title: TA Head, PKS Immunology Location: Basel We are seeking an accomplished and visionary scientific leader to join us as TA Head, PK Sciences (PKS) Immunology. In this
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Main Responsibilities: Manage employee onboarding, employment changes, and offboarding Prepare employment contracts, amendments, certificates, and HR documentation Maintain accurate personnel records and HR systems Coordinate timesheet oversight and reconciliation activities; and contribute to employee salary preparations
Overview Are you an expert in Electrical Engineering with experience in supporting Industrial, Mission Critical or Life Sciences CAPEX projects? We have a fantastic opportunity for an experienced and talented Electrical Engineer to join our growing team
ROLE OVERVIEW Lead the way in safe and smooth navigation, delivering unparalleled comfort and satisfaction. Reporting directly to the Captain, youll showcase your maritime expertise and create unforgettable experiences for our guests. WHAT YOU WILL DO
Please note that we can only accept applicants who are eligible to work in Europe or in possession of a valid work permit. CAPTAIN River - Nautic ROLE OVERVIEW Ensure safe and seamless navigation of our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About the BIIE The Botnar Institute of Immune Engineering is an independent, non‑profit research institute dedicated to transforming global child and adolescent health. Operating in strategic partnership with ETH Zurich and the University of Oxford, we
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Industry: Marketing & Event Industry Number of employees: approx 1400 worldwide / 400 CH Reference number: 63X587WR Key Facts: SAP HR Ownership, SAP SuccessFactors, SAP Concur, SAP Cloud Platform integrations, project management, stakeholder management, in Basel/home